Strickler, J. H., Fakih, M., Price, T. J., Desai, J., Durm, G., Krauss, J. C., … Hong, D. S. (2020). 83MO AMG 510, a novel small molecule inhibitor of KRAS(G12C), for patients (pts) with advanced gastrointestinal (GI) cancers: Results from the CodeBreaK100 phase I trial. In Annals of Oncology (Vol. 31, pp. S1274–S1275). Elsevier BV. https://doi.org/10.1016/j.annonc.2020.10.103

Strickler, J. H., M. Fakih, T. J. Price, J. Desai, G. Durm, J. C. Krauss, Y. Kuboki, et al. “83MO AMG 510, a novel small molecule inhibitor of KRAS(G12C), for patients (pts) with advanced gastrointestinal (GI) cancers: Results from the CodeBreaK100 phase I trial.” In Annals of Oncology, 31:S1274–75. Elsevier BV, 2020. https://doi.org/10.1016/j.annonc.2020.10.103.

Strickler JH, Fakih M, Price TJ, Desai J, Durm G, Krauss JC, et al. 83MO AMG 510, a novel small molecule inhibitor of KRAS(G12C), for patients (pts) with advanced gastrointestinal (GI) cancers: Results from the CodeBreaK100 phase I trial. In: Annals of Oncology. Elsevier BV; 2020. p. S1274–5.

Strickler, J. H., et al. “83MO AMG 510, a novel small molecule inhibitor of KRAS(G12C), for patients (pts) with advanced gastrointestinal (GI) cancers: Results from the CodeBreaK100 phase I trial.” Annals of Oncology, vol. 31, Elsevier BV, 2020, pp. S1274–75. Crossref, doi:10.1016/j.annonc.2020.10.103.

Strickler JH, Fakih M, Price TJ, Desai J, Durm G, Krauss JC, Kuboki Y, Kim TW, Sacher A, Henary H, Kim J, Hong DS. 83MO AMG 510, a novel small molecule inhibitor of KRAS(G12C), for patients (pts) with advanced gastrointestinal (GI) cancers: Results from the CodeBreaK100 phase I trial. Annals of Oncology. Elsevier BV; 2020. p. S1274–S1275.